Pharmaceutical Innovation
Beyond the Copy: Seven Indian Pharma Companies Quietly Rewriting the Rules of Drug Discovery for US Patients
India's pharmaceutical identity in the American market has long been synonymous with affordable generics — but a quieter transformation is underway in research laboratories from Bangalore to Mumbai. A new cohort of Indian drug developers is advancing novel molecules, pioneering rare disease therapies, and running late-stage clinical trials that are reshaping how the US healthcare community perceives Indian pharma's innovative capacity. These are the companies and programs worth watching.
